©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hematol. Jan 17, 2023; 10(2): 15-24
Published online Jan 17, 2023. doi: 10.5315/wjh.v10.i2.15
Published online Jan 17, 2023. doi: 10.5315/wjh.v10.i2.15
Advantageous tactics with certain probiotics for the treatment of graft-versus-host-disease after hematopoietic stem cell transplantation
Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, Yuka Ikeda, Ai Tsuji, Satoru Matsuda, Food Science and Nutrition, Nara Women's University, Nara 630-8506, Japan
Author contributions: Yoshikawa S and Matsuda S contributed conception of the study; Yoshikawa S, Taniguchi K, Sawamura H, Ikeda Y, Tsuji A, and Matsuda S wrote sections of the manuscript; all authors contributed to manuscript revision, and have read and given final approval of the version to be submitted.
Conflict-of-interest statement: All the authors declare that they have no competing financial interest.
Corresponding author: Satoru Matsuda, MD, PhD, Professor, Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan.
Received: August 2, 2022
Peer-review started: August 2, 2022
First decision: October 21, 2022
Revised: November 3, 2022
Accepted: November 23, 2022
Article in press: November 23, 2022
Published online: January 17, 2023
Processing time: 167 Days and 20.4 Hours
Peer-review started: August 2, 2022
First decision: October 21, 2022
Revised: November 3, 2022
Accepted: November 23, 2022
Article in press: November 23, 2022
Published online: January 17, 2023
Processing time: 167 Days and 20.4 Hours
Core Tip
Core Tip: Potential efficacy of probiotics for the treatment of graft vs host disease after hematopoietic stem cell transplantation has been shown here.